The Federal Trade Commission on Friday sued prescription-drug middlemen ... agrees with the FTC’s point that “PBMs have leveraged their position as powerful industry middlemen and have ...

The FTC accused the companies of creating a “perverse” drug rebate system that prioritizes insulin from manufacturers sold at a higher list price even when cheaper versions are available.

FTC Sues Drug Middlemen Over Manipulating Insulin Market Lower-cost versions of insulin weren’t covered by group plans Drug benefit managers accused of illegally inflating prices ...

Sept. 20 (UPI) --The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns the companies are artificially inflating the list ...

CVS Health’s Caremark and Cigna’s Express Scripts have created a “perverse” drug rebate system that has “artificially inflated” the price of insulin, the FTC alleges. The FTC claims ...

The FTC brought action against the top PBMs ... PBMs are essentially the middlemen between drug manufacturers and insurance providers. Their job is to reduce drug prices.

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of ... conflict between the FTC and the three ...

The FTC on Friday sued three prescription drug gatekeepers, alleging they worked to artificially increase the price of insulin to boost their profits. Kevin Dietsch/Getty Images The three - CVS ...

study says Pfizer's gene therapy for rare genetic bleeding disorder succeeds in trial Lawmakers introduce bipartisan bill aiming to crack down on drug middlemen The FTC said it remains "deeply ...